Directly from Silmo Paris 2022’s Trends Forum, Vanni’s new Dama line, made with the company’s exclusive acetate, captures reflections and transforms them into shimmering movement on the frames’ surface. The name was inspired by the material’s resemblance to the pearlescent sheen of damask fabrics, s
Dispensing optician Pene Fox has launched Bespectacled Optical Dispensary.
Israel’s Azura Ophthalmics announced positive three-month efficacy and safety results from its phase 2b study on its keratolytic eye preparation AZR-MD-001 0.5% in meibomian gland dysfunction (MGD).
Designed by New Zealand optometrist and entrepreneur Paul Rose for post-surgery patients, a new contact lens for irregular corneas, the Rose K2 XL oblate, has been unveiled by Menicon.
Having delayed the company’s European push because of Covid, the British eyewear designer and manufacturer Eyespace debuted at Silmo 2022, unveiling its first optical range for Range Rover and previewing optical and sun ranges for its other licensed brands, Land Rover and Aspinal of London.
Matthews Eyecare has appointed Michael Cochrane as its new chief executive, replacing owner Phil Matthews, who will step down to focus on his strategic governance role on the company’s board.
An independent inquiry into the workplace culture at Blind and Low Vision New Zealand (BLVNZ), found an already poor culture was made worse by the transformation work initiated in 2019, but is now improving thanks to organisational and policy change.
A new survey by the Australia and New Zealand Child Myopia Working Group found 28% of New Zealand’s under-18s have never visited an optometrist for an eye check – a figure unchanged since a similar 2018 survey.
The Optometrists and Dispensing Opticians Board’s (ODOB) practitioner portals and public website have fallen victim to a cyber-attack, preventing access to many of the Board’s core systems. The attack
It was great to be able to attend this in-person Australian & New Zealand Strabismus Society (ANZSS) meeting and catch up with colleagues from around the country after the last couple of years of Covid disruptions. The large group of attendees happily generated lots of discussion throughout the
Aldeyra has announced the submission of a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for topical ocular reproxalap, an investigational new drug candidate for the treatment
Sporting new, still to be patented, screwless-hinge technology, JF Rey’s new Olympus range epitomises the evolution of the company under new owners Walter Pirinoli, Dan Levi and Ralf Kmoch, said Levi at Silmo 2022. Since taking the reins of the French eyewear firm just over a year ago, the new owner